Study Stopped
due to lack of recruitment
Seropositivity and Adverse Birth Events in Migrants From Bilharzia-endemic Areas
Bilharzia
Association of Schistosomiasis Seropositivity With Adverse Birth Events in Migrants From Bilharzia-endemic Areas
1 other identifier
observational
82
1 country
1
Brief Summary
The study intends to examine the association between schistosomiasis seropositivity and adverse pregnancy outcomes. It aims at the verification of the hypothesis that in pregnant women originating from endemic areas for schistosomiasis, positive serology is associated with reduced Infant birth weight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2017
CompletedFirst Posted
Study publicly available on registry
May 18, 2017
CompletedStudy Start
First participant enrolled
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 11, 2019
CompletedResults Posted
Study results publicly available
April 14, 2022
CompletedApril 14, 2022
April 1, 2022
1.4 years
May 16, 2017
July 6, 2020
April 13, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Schistosoma Serology
Presence of Schistosoma antibodies in maternal serum
6 month after delivery
Secondary Outcomes (4)
Birth Weight
1 hour upon delivery
Preterm Birth
24 hours before delivery
Intrauterine Growth Restriction
48 hours after delivery
Stillbirth
At delivery
Interventions
Maternal blood sample of 10 ml collected by venepuncture upon delivery
Eligibility Criteria
Pregnant women aged above 18, who migrated to Europe from geographic regions with endemic schistosomiasis
You may qualify if:
- Pregnancy
- Immigration from a country/geographic area with declared endemic schistosomiasis according to World Health Organization criteria
- Signed informed consent
You may not qualify if:
- Placenta pathology of any cause
- Any medical condition affecting fetal growth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jena University Hospitallead
- Technical University of Munichcollaborator
- Charite University, Berlin, Germanycollaborator
- University Hospital in Hallecollaborator
Study Sites (1)
University Hospital Jena
Jena, Thuringia, 07747, Germany
Biospecimen
Serum Placenta (optional)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Early termination leading to small numbers of subjects analyzed
Results Point of Contact
- Title
- Dr. Benjamin Schleenvoigt
- Organization
- Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin Schleenvoigt, M.D.
Center for Infectious Diseases and Infection Control, Jena University Hospital
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2017
First Posted
May 18, 2017
Study Start
June 1, 2017
Primary Completion
October 31, 2018
Study Completion
October 11, 2019
Last Updated
April 14, 2022
Results First Posted
April 14, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share